Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06701084 · ClinicalTrials.gov registry record · NA
Molecular Genetic Mechanisms of Infantile Epilepsies and the Impact of Genetic Diagnosis
A NA study of Neonatal Epilepsy and Infantile Epilepsy, sponsored by Boston Children's Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 600
- Enrollment target
- 1
- Study location
NCT06701084: Recruiting NA study of Neonatal Epilepsy and Infantile Epilepsy, sponsored by Boston Children's Hospital.
NCT06701084 is a NA study of Neonatal Epilepsy and Infantile Epilepsy that is actively recruiting participants, run by Boston Children's Hospital. The registered enrollment target is 600 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (57% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06701084, a NA study of Neonatal Epilepsy and Infantile Epilepsy, is actively recruiting participants, sponsored by Boston Children's Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 600 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to discover new genetic causes of infantile epilepsies and evaluate the impact of these discoveries on infants with epilepsy and their families.
Primary Outcome
The diagnostic yield of genomic sequencing will be calculated as the percentage of enrolled infants with epilepsy who receive a genetic diagnosis.
Conditions Studied
Interventions
- GENETIC Genomic Sequencing
Study Locations (1)
Massachusetts
- Boston Children's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2021-09-02 |
| Est. Completion | 2029-11 |
| Phase | NA |
What NCT06701084 shows while recruiting
NCT06701084 is an interventional study that assigns participants to a tested intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (57% lower).
The record links to 2 conditions, with Neonatal Epilepsy appearing as the primary indexed condition, and to 1 intervention - of which Genomic Sequencing is the first listed.
NCT06701084 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06701084 about?
NCT06701084 is a clinical study titled "Molecular Genetic Mechanisms of Infantile Epilepsies and the Impact of Genetic Diagnosis". The goal of this study is to discover new genetic causes of infantile epilepsies and evaluate the impact of these discoveries on infants with epilepsy and their families.
What is the current status of trial NCT06701084?
This trial is currently recruiting. It is a NA study. The enrollment target is 600 participants. The study started on 2021-09-02. Estimated completion is 2029-11.
What conditions does trial NCT06701084 study?
This clinical trial studies the following conditions: Neonatal Epilepsy, Infantile Epilepsy.
What interventions are being tested in trial NCT06701084?
The interventions under investigation include: Genomic Sequencing (GENETIC).
Who is sponsoring clinical trial NCT06701084?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06701084 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06701084's enrollment target sits among peer trials
600 162nd of 2000 higher than 1,827 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI